Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2

Rachel J. Hagey, Menashe Elazar, Edward A. Pham, Siqi Tian, Lily Ben‐Avi, Claire Bernardin-Souibgui, Matthew Yee, Fernando R. Moreira, Meirav Vilan Rabinovitch, Rita M. Meganck, Benjamin Fram, Aimee Beck, Scott Gibson, Grace Y. Lam, Josephine Devera, Wipapat Kladwang, Khanh Cong Nguyen, Anming Xiong, Steven Schaffert, Talia Avisar, Ping Liu, Arjun Rustagi, Carl J. Fichtenbaum, Phillip S. Pang, Purvesh Khatri, Chien‐Te K. Tseng, Jeffery K. Taubenberger, Catherine A. Blish, Brett L. Hurst, Timothy P. Sheahan, Rhiju Das, Jeffrey S. Glenn